Host factors associated with outcome from primary human immunodeficiency virus-1 infection

被引:6
作者
Telenti, Amalio [1 ,2 ]
Carrington, Mary [3 ]
机构
[1] Univ Lausanne, Inst Microbiol, CH-1011 Lausanne, Switzerland
[2] Univ Hosp Ctr, Inst Microbiol, CH-1011 Lausanne, Switzerland
[3] NCI Frederick, Canc & Inflammat Program, Expt Immunol Lab, SAIC Frederick Inc, Frederick, MD 21702 USA
基金
美国国家卫生研究院; 瑞士国家科学基金会;
关键词
genome; HLA antigens; KIR receptors; viral load;
D O I
10.1097/COH.0b013e3282f18ac0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose of review The early events in human immunodeficiency virus-1 infection are increasingly recognized as critical for the overall evolution of the disease. Viral and host factors interact to establish a point of equilibrium defined by the viral set point. This review highlights new opportunities in the understanding of the genetic and genomic determinants of those early events. Recent findings The field of human immunodeficiency virus host genetics is shifting from the measure of long-term consequences of infection to the analysis of quantitative biological endpoints of viral control, with particular attention on the earliest events as study phenotypes. The field has also been enriched by a better understanding of the determinant and complex role of human leukocyte antigen and killer cell immunoglobulin-like-receptor variation, and by the completion of the first genome-wide study of determinants of human immunodeficiency virus-1 replication. The genome analysis highlights the central influence of acquired immunity in viral control, and provides an extensive catalogue of novel gene candidates. Summary Host genetics and genomic analyses of precise quantitative study phenotypes offer an unprecedented opportunity to dissect critical steps in human immunodeficiency virus-1 pathogenesis.
引用
收藏
页码:28 / 35
页数:8
相关论文
共 50 条
  • [21] Chromatin dynamics during herpes simplex virus-1 lytic infection
    Placek, Brandon J.
    Berger, Shelley L.
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2010, 1799 (3-4): : 223 - 227
  • [22] Metabolic syndrome in Zambian adults with human immunodeficiency virus on antiretroviral therapy Prevalence and associated factors
    Hamooya, Benson M.
    Mulenga, Lloyd B.
    Masenga, Sepiso K.
    Fwemba, Isaac
    Chirwa, Lameck
    Siwingwa, Mpanji
    Halwiindi, Hikabasa
    Koethe, John R.
    Lipworth, Loren
    Heimburger, Douglas C.
    Musonda, Patrick
    Mutale, Wilbroad
    MEDICINE, 2021, 100 (14) : E25236
  • [23] Association of CD209L tandem repeats polymorphism with susceptibility to human immunodeficiency virus-1 infection, disease progression, and treatment outcomes: a Moroccan cohort study
    Fayssel, N.
    Bensghir, R.
    Ouladlahsen, A.
    Abdelghaffar, H.
    Sodqi, M.
    Lahlou, K.
    Benjelloun, S.
    El Filali, K. Marhoum
    Ezzikouri, S.
    Wakrim, L.
    CLINICAL MICROBIOLOGY AND INFECTION, 2015, 21 (05) : 513.e1 - 513.e5
  • [24] Dynamics and Correlates of CD8 T-Cell Counts in Africans with Primary Human Immunodeficiency Virus Type 1 Infection
    Prentice, Heather A.
    Lu, Hailin
    Price, Matthew A.
    Kamali, Anatoli
    Karita, Etienne
    Lakhi, Shabir
    Sanders, Eduard J.
    Anzala, Omu
    Allen, Susan
    Goepfert, Paul A.
    Hunter, Eric
    Gilmour, Jill
    Tang, Jianming
    JOURNAL OF VIROLOGY, 2016, 90 (22) : 10423 - 10430
  • [25] Genetic diversity among human immunodeficiency virus-1 non-B subtypes in viral load and drug resistance assays
    Peeters, M.
    Aghokeng, A. F.
    Delaporte, E.
    CLINICAL MICROBIOLOGY AND INFECTION, 2010, 16 (10) : 1525 - 1531
  • [26] Effectiveness of early initiation of protease inhibitor-sparing antiretroviral regimen in human immunodeficiency virus-1 vertically infected infants
    Van der Linden, Dimitri
    Hainaut, Marc
    Goetghebuer, Tessa
    Haelterman, Edwige
    Schmitz, Veronique
    Maes, Philip
    Peltier, Alexandra
    Levy, Jack
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2007, 26 (04) : 359 - 361
  • [27] Detection of human immunodeficiency virus-1 ribonucleic acid in the peritoneal effluent of renal failure patients on highly active antiretroviral therapy
    Ndlovu, Kwazi C. Z.
    Sibanda, Wilbert
    Assounga, Alain
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 (04) : 714 - 721
  • [28] Breadth of Neutralizing Antibody Response to Human Immunodeficiency Virus Type 1 Is Affected by Factors Early in Infection but Does Not Influence Disease Progression
    Piantadosi, Anne
    Panteleeff, Dana
    Blish, Catherine A.
    Baeten, Jared M.
    Jaoko, Walter
    McClelland, R. Scott
    Overbaugh, Julie
    JOURNAL OF VIROLOGY, 2009, 83 (19) : 10269 - 10274
  • [29] Human immunodeficiency virus-associated vasculopathy with CNS compartmentalization of HIV-1
    Bruno Fukelmann Guedes
    Helio Rodrigues Gomes
    Leadro Tavares Lucato
    Paulo Puglia
    Ricardo Nitrini
    Luiz Henrique Martins Castro
    Journal of NeuroVirology, 2015, 21 : 101 - 104
  • [30] Human immunodeficiency virus-associated vasculopathy with CNS compartmentalization of HIV-1
    Guedes, Bruno Fukelmann
    Gomes, Helio Rodrigues
    Lucato, Leadro Tavares
    Puglia, Paulo, Jr.
    Nitrini, Ricardo
    Martins Castro, Luiz Henrique
    JOURNAL OF NEUROVIROLOGY, 2015, 21 (01) : 101 - 104